Italy · Series B startup

Who invested in AAVantgarde Bio

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 12 months ago

Funding summaryUpdated 26 Oct 2026

$141Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $141MNov 2025
Investors
4
See who backed them

The rounds

  1. Nov 2025

Everyone who backed them

Sofinnova PartnersVC firm1round
CDP Venture CapitalVC firm1round
Forbion Capital PartnersPrivate equity1round
Longwood FundVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists AAVantgarde Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Atlas VentureVC firmPer its own site

Quick answers about AAVantgarde Bio

Who invested in AAVantgarde Bio?

AAVantgarde Bio's investors include Sofinnova Partners, CDP Venture Capital, Forbion Capital Partners and Longwood Fund.

How much has AAVantgarde Bio raised?

AAVantgarde Bio has raised $141M across 1 round since 2025.

When did AAVantgarde Bio last raise?

AAVantgarde Bio's most recent round was a Series B of $141M in Nov 2025.

What was AAVantgarde Bio's biggest round?

Its most recent round, $141M in Nov 2025, is also its largest on record.

Who backed AAVantgarde Bio first?

AAVantgarde Bio's first round on record, in Nov 2025, was backed by Sofinnova Partners, CDP Venture Capital and Forbion Capital Partners and 1 others.

What stage is AAVantgarde Bio at?

AAVantgarde Bio's latest named round is a Series B, in Nov 2025.

Where is AAVantgarde Bio based?

AAVantgarde Bio is based in Italy.

Companies like AAVantgarde Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.